Inovio Pharmaceuticals (INO) Falls on Rumor of Drug Test Failure

Shares of pharmaceutical research company Inovio Pharmaceuticals, Inc. (INO) fell on Tuesday against the backdrop of a higher day for the markets overall. The stock fell $1.44 per share, down 13.36%, to close at $9.34. The activity came on volume of 11,407,818 shares, compared to average daily volume of 1.521 million shares. The stock fell after The Street's Adam Feuerstein suggested that studies conducted on a promising new drug may have failed.

Founded in 1983 and based in Blue Bell, Pennsylvania, Inovio Pharmaceuticals, Inc. is involved in research and development of new vaccines and immune therapies ("synthetic vaccines"

Published on Jun 11, 2014
By Kevin Mercadante

Copyrighted 2016. Content published with author's permission.

Posted in ...